BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17270609)

  • 1. Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome.
    Byun SS; Yeo WG; Lee SE; Lee E
    Urology; 2007 Jan; 69(1):34-7. PubMed ID: 17270609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.
    Parker AS; Kosari F; Lohse CM; Houston Thompson R; Kwon ED; Murphy L; Riehle DL; Blute ML; Leibovich BC; Vasmatzis G; Cheville JC
    Cancer; 2006 Jul; 107(1):37-45. PubMed ID: 16736510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
    Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
    Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
    Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
    Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
    Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
    J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metallothionein expression in renal cell carcinoma: subcellular localization and prognostic significance.
    Tüzel E; Kirkali Z; Yörükoglu K; Mungan MU; Sade M
    J Urol; 2001 May; 165(5):1710-3. PubMed ID: 11342961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S; Unsal E; Demirag F; Köksal D; Yilmaz A
    Respir Med; 2006 Dec; 100(12):2220-6. PubMed ID: 16650973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 is an independent prognostic factor in conventional renal cell carcinomas.
    Paradis V; Ferlicot S; Ghannam E; Zeimoura L; Blanchet P; Eschwége P; Jardin A; Benoît G; Bedossa P
    J Urol; 1999 Jun; 161(6):1984-7. PubMed ID: 10332486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma.
    Li YH; Hu CF; Shao Q; Huang MY; Hou JH; Xie D; Zeng YX; Shao JY
    J Transl Med; 2008 Jan; 6():1. PubMed ID: 18171482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
    Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
    Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivin expression is associated with features of biologically aggressive prostate carcinoma.
    Shariat SF; Lotan Y; Saboorian H; Khoddami SM; Roehrborn CG; Slawin KM; Ashfaq R
    Cancer; 2004 Feb; 100(4):751-7. PubMed ID: 14770431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of periodic acid-Schiff-positive patterns in clear cell renal cell carcinoma.
    Vartanian AA; Stepanova EV; Gutorov SL; Solomko ESh; Grigorieva IN; Sokolova IN; Baryshnikov AY; Lichinitser MR
    Can J Urol; 2009 Aug; 16(4):4726-32. PubMed ID: 19671223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.
    Zhang Z; Li J; Zheng H; Yu C; Chen J; Liu Z; Li M; Zeng M; Zhou F; Song L
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2685-93. PubMed ID: 19755649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression predicts early recurrence in early-stage breast cancer.
    Yamashita S; Masuda Y; Kurizaki T; Haga Y; Murayama T; Ikei S; Kamei M; Takeno S; Kawahara K
    Anticancer Res; 2007; 27(4C):2803-8. PubMed ID: 17695451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
    Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas.
    Zhang Y; Huang D; Yu G
    Acta Otolaryngol; 2005 Dec; 125(12):1345-50. PubMed ID: 16303685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
    Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
    Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of COX-2 and survivin expression in ovarian cancer.
    Athanassiadou P; Grapsa D; Athanassiades P; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
    Pathol Res Pract; 2008; 204(4):241-9. PubMed ID: 18171606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular tumor invasion: prognostic significance in low-stage renal cell carcinoma.
    Madbouly K; Al-Qahtani SM; Ghazwani Y; Al-Shaibani S; Mansi MK
    Urology; 2007 Apr; 69(4):670-4. PubMed ID: 17445649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy.
    Suzuki Y; Oka K; Yoshida D; Shirai K; Ohno T; Kato S; Tsujii H; Nakano T
    Gynecol Oncol; 2007 Mar; 104(3):642-6. PubMed ID: 17141299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.